EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 13 rujna 2024. Database contains 4917 unique substances/entries.
Filter the list

 
231-634-8
7664-39-3
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A
Details
231-634-8
7664-39-3
Acute Tox. 2; Acute Tox. 1; Skin Corr. 1A
Details
215-605-7
1333-74-0
Flam. Gas 1; Press. Gas
Details
200-821-6
74-90-8
Acute Tox. 2; Acute Tox. 1
Details
200-821-6
74-90-8
Flam. Liq. 1; Acute Tox. 2
Details
231-765-0
7722-84-1
Ox. Liq. 1; Acute Tox. 4; Skin Corr. 1A
Details
2-BUTANEDIOIC ACID, MONOAMIDE WITH N-(9-OCTADECENYL)-3-AMINO
402-970-4
148292-42-6
Skin Sens. 1
Details
231-977-3
7783-06-4
Press. Gas; Acute Tox. 2
Details
SICORIN E 10197
403-750-0
113036-91-2
Acute Tox. 4
Details
423-310-1
61420-92-6
Acute Tox. 4; STOT RE 2; Skin Corr. 1A; Resp. Sens. 1; Skin Sens. 1
Details
641-410-5
130066-44-3
Skin Sens. 1A
Details
232-259-2
7803-49-8
Unst. Expl.; Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
232-259-2
7803-49-8
Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
Details
258-872-5
53933-48-5
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
242-818-2
19098-16-9
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
244-077-0
20845-01-6
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
226-798-2
5470-11-1
Met. Corr. 1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
233-154-4
10046-00-1
Expl. 1.1; Carc. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
236-691-2
13465-08-2
Expl. 1.1; Carc. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
Details
DP-3337
405-710-8
23783-26-8
Acute Tox. 4; STOT RE 2; Skin Corr. 1B; Skin Sens. 1
Details
-
-
P Parasites
Details
-
-
P Parasites
Details
233-000-6
10004-44-1
Repr. 2; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
Details
200-090-3
51-34-3
Acute Tox. 2; Acute Tox. 1
Details
202-933-0
101-31-5
Acute Tox. 2
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
252-615-0
35554-44-0
Carc. 2; Acute Tox. 3; Acute Tox. 4; Eye Dam. 1
Details
261-351-5
58594-72-2
Acute Tox. 4; Skin Sens. 1
Details
261-351-5
58594-72-2
Acute Tox. 4; Skin Corr. 1B; Skin Sens. 1
Details
601-305-7
114311-32-9
Repr. 2
Details
617-219-8
81334-34-1
Eye Irrit. 2
Details
428-040-8
138261-41-3
Acute Tox. 3
Details
431-510-5
18087-70-2
Acute Tox. 4; Eye Irrit. 2
Details
206-019-2
288-32-4
Repr. 1B; Acute Tox. 4; Skin Corr. 1C
Details
428-790-6
72963-72-5
Carc. 2; Acute Tox. 4; STOT SE 2
Details
244-959-5
22398-80-7
Carc. 1B; Repr. 2; STOT RE 1
Details
605-683-4
173584-44-6
Acute Tox. 3; Acute Tox. 4; STOT RE 1; Skin Sens. 1B
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
Acute Tox. 2; Acute Tox. 1; STOT RE 2
Details
231-442-4
7553-56-2
Acute Tox. 4
Details
200-590-1
64-69-7
Acute Tox. 3; Skin Corr. 1A
Details
-
696-33-3
Expl.
Details
216-881-1
1689-83-4
Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2
Details
223-375-4
3861-47-0
Repr. 2; Acute Tox. 3; Eye Irrit. 2; Skin Sens. 1
Details
603-038-1
125225-28-7
Repr. 1B; Acute Tox. 4; STOT RE 2
Details
247-449-0
26087-47-8
Acute Tox. 4
Details
253-178-9
36734-19-7
Carc. 2
Details
604-209-3
140923-17-7
Carc. 2
Details
-
5827-05-4
Acute Tox. 1; Acute Tox. 3
Details
231-753-5
7720-78-7
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
Details
616-510-7
7782-63-0
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2
Details
JOF 2822 5F; JOF 2822 5FL; JOF 4443
420-960-8
77214-82-5
Eye Dam. 1
Details
255-863-8
42509-80-8
Acute Tox. 2; Acute Tox. 3; STOT RE 2; Skin Sens. 1
Details
208-746-0
540-42-1
Flam. Liq. 3
Details
206-045-4
297-78-9
Acute Tox. 1; Acute Tox. 2
Details
200-857-2
75-28-5
Flam. Gas 1; Press. Gas; Carc. 1A; Muta. 1B
Details
200-857-2
75-28-5
Flam. Gas 1; Press. Gas
Details
-
51337-71-4
Acute Tox. 4
Details
IVAX
401-920-9
100181-71-3
Skin Irrit. 2; Skin Sens. 1
Details
203-745-1
110-19-0
Flam. Liq. 2
Details
203-417-8
106-63-8
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1
Details
ISOBUTYLVINYL ACETATE; IVA
401-170-2
24342-03-8
Flam. Liq. 3
Details
208-818-1
542-55-2
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3
Details
202-613-0
97-86-9
Flam. Liq. 3; STOT SE 3; Skin Irrit. 2; Skin Sens. 1B
Details
208-819-7
542-56-3
Flam. Liq. 2; Carc. 1B; Muta. 2; Acute Tox. 4
Details
ZOLDINE RD-4
419-850-2
148348-13-4
Skin Corr. 1B
Details
ALKYLSILANE TZ 01748; DYNASYLAN 9405; EURENOR(R) 5020; PSX 5305
402-580-4
111439-76-0
Flam. Liq. 3; Acute Tox. 4; Skin Irrit. 2
Details
201-195-7
79-31-2
Acute Tox. 4
Details
201-194-1
79-30-1
Flam. Liq. 2; Skin Corr. 1A
Details
207-366-2
465-73-6
Acute Tox. 2; Acute Tox. 1
Details
202-590-7
97-54-1
Skin Sens. 1A
Details
246-814-1
25311-71-1
Acute Tox. 3
Details
250-610-8
31394-54-4
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
Details
247-861-0
26635-64-3
Flam. Liq. 2; Asp. Tox. 1; Skin Irrit. 2; STOT SE 3
Details
249-707-8
29590-42-9
Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
201-142-8
78-78-4
Flam. Liq. 1; Asp. Tox. 1; STOT SE 3
Details
204-662-3
123-92-2
Flam. Liq. 3
Details
203-769-2
110-45-2
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3
Details
203-322-1
105-68-0
Flam. Liq. 3
Details
201-143-3
78-79-5
Flam. Liq. 1; Carc. 1B; Muta. 2
Details
220-114-6
2631-40-5
Acute Tox. 4
Details
203-561-1
108-21-4
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3
Details
203-301-7
105-48-6
Flam. Liq. 3; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2
Details
210-901-2
625-55-8
Flam. Liq. 2; Eye Irrit. 2; STOT SE 3
Details
211-300-8
637-78-5
Flam. Liq. 2
Details
417-970-1
1379932-74-7
Acute Tox. 3; Acute Tox. 4; STOT RE 1; Eye Dam. 1
Details
251-835-4
34123-59-6
Carc. 2; STOT RE 2
Details
259-782-9
55738-53-9
Skin Irrit. 2
Details
-
36614-38-7
Acute Tox. 3
Details
604-222-4
141112-29-0
Repr. 2
Details
242-624-8
18854-01-8
Acute Tox. 3
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
-
-
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans.
Details
620-410-9
4234-79-1
Acute Tox. 3; Acute Tox. 4
Details
A complex combination of hydrocarbons obtained by fractionation from hydrodesulfurized thermal cracker distillate. It consists predominantly of hydrocarbons predominantly in the range of C8 to C16 and boiling in the range of approximately 120°C to 283°C (284°F to 541°F).
285-507-7
85116-55-8
Asp. Tox. 1
Details
A complex combination of hydrocarbons obtained from a petroleum stock by treating with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly in the range of C9 through C16 and boiling in the range of approximately 150°C to 290°C (302°F to 554°F).
265-184-9
64742-81-0
Asp. Tox. 1
Details
A complex combination of hydrocarbons obtained from the distillation of petroleum and subsequent hydrotreatment. It consists predominantly of alkanes, cycloalkanes and alkylbenzenes having carbon numbers predominantly in the range of C12 through C16 and boiling in the range of approximately 230°C to 270°C (446°F to 518°F).
309-944-0
101631-19-0
Asp. Tox. 1
Details
307-033-2
97488-94-3
Asp. Tox. 1
Details
A complex combination of hydrocarbons obtained from a petroleum stock by solvent refining and sweetening and boiling in the range of approximately 150°C to 260°C (302°F to 500°F).
295-416-4
92045-36-8
Asp. Tox. 1
Details
A complex combination of hydrocarbons obtained as a wide cut hydrocarbon fuel cut from atmospheric distillation and boiling in the range of approximately 70°C to 220°C (158°F to 428°F).
295-418-5
92045-37-9
Asp. Tox. 1
Details

Export search results to: